Emerging Roles of RAD52 in Genome Maintenance
- PMID: 31340507
- PMCID: PMC6679097
- DOI: 10.3390/cancers11071038
Emerging Roles of RAD52 in Genome Maintenance
Abstract
The maintenance of genome integrity is critical for cell survival. Homologous recombination (HR) is considered the major error-free repair pathway in combatting endogenously generated double-stranded lesions in DNA. Nevertheless, a number of alternative repair pathways have been described as protectors of genome stability, especially in HR-deficient cells. One of the factors that appears to have a role in many of these pathways is human RAD52, a DNA repair protein that was previously considered to be dispensable due to a lack of an observable phenotype in knock-out mice. In later studies, RAD52 deficiency has been shown to be synthetically lethal with defects in BRCA genes, making RAD52 an attractive therapeutic target, particularly in the context of BRCA-deficient tumors.
Keywords: BRCA1; BRCA2; DNA repair; R-loops; RAD51; RAD52; RNA:DNA hybrids; double-strand break repair; genome instability; synthetic lethality.
Conflict of interest statement
The authors declare no conflict of interest.
Figures


Similar articles
-
RAD52 inactivation is synthetically lethal with deficiencies in BRCA1 and PALB2 in addition to BRCA2 through RAD51-mediated homologous recombination.Oncogene. 2013 Jul 25;32(30):3552-8. doi: 10.1038/onc.2012.391. Epub 2012 Sep 10. Oncogene. 2013. PMID: 22964643 Free PMC article.
-
Reappearance from Obscurity: Mammalian Rad52 in Homologous Recombination.Genes (Basel). 2016 Sep 14;7(9):63. doi: 10.3390/genes7090063. Genes (Basel). 2016. PMID: 27649245 Free PMC article. Review.
-
Replication Protein A Phosphorylation Facilitates RAD52-Dependent Homologous Recombination in BRCA-Deficient Cells.Mol Cell Biol. 2022 Feb 17;42(2):e0052421. doi: 10.1128/mcb.00524-21. Epub 2021 Dec 20. Mol Cell Biol. 2022. PMID: 34928169 Free PMC article.
-
Therapeutic exploitation of tumor cell defects in homologous recombination.Anticancer Agents Med Chem. 2008 May;8(4):448-60. doi: 10.2174/187152008784220267. Anticancer Agents Med Chem. 2008. PMID: 18473729 Review.
-
The endonuclease EEPD1 mediates synthetic lethality in RAD52-depleted BRCA1 mutant breast cancer cells.Breast Cancer Res. 2017 Nov 16;19(1):122. doi: 10.1186/s13058-017-0912-8. Breast Cancer Res. 2017. PMID: 29145865 Free PMC article.
Cited by
-
The high toxicity of DSB-clusters modelling high-LET-DNA damage derives from inhibition of c-NHEJ and promotion of alt-EJ and SSA despite increases in HR.Front Cell Dev Biol. 2022 Oct 3;10:1016951. doi: 10.3389/fcell.2022.1016951. eCollection 2022. Front Cell Dev Biol. 2022. PMID: 36263011 Free PMC article.
-
Conditionally immortalised leukaemia initiating cells co-expressing Hoxa9/Meis1 demonstrate microenvironmental adaptation properties ex vivo while maintaining myelomonocytic memory.Sci Rep. 2021 Mar 5;11(1):5294. doi: 10.1038/s41598-021-84468-3. Sci Rep. 2021. PMID: 33674652 Free PMC article.
-
Analyzing the Opportunities to Target DNA Double-Strand Breaks Repair and Replicative Stress Responses to Improve Therapeutic Index of Colorectal Cancer.Cancers (Basel). 2021 Jun 23;13(13):3130. doi: 10.3390/cancers13133130. Cancers (Basel). 2021. PMID: 34201502 Free PMC article. Review.
-
RAD52: Viral Friend or Foe?Cancers (Basel). 2020 Feb 8;12(2):399. doi: 10.3390/cancers12020399. Cancers (Basel). 2020. PMID: 32046320 Free PMC article. Review.
-
Comparative analysis of multiple DNA double-strand break repair pathways in CRISPR-mediated endogenous tagging.Commun Biol. 2025 May 13;8(1):749. doi: 10.1038/s42003-025-08187-5. Commun Biol. 2025. PMID: 40360740 Free PMC article.
References
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous